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Purpose and objectives: We report an additionally case o f uterine myoma.
Materials and Methods: A 20 years old female patient was admitted with an giant 
abdominal tum or which raised in two months with an uterine provenience. This tumor was 
confirmed by clinical examination, USG and CT-scan.
Result: During the surgery, was suspected a malignant uterine tumor. This patient support a 
total hysterectomy surgery, but histological examination and immunohistochemical analysis proved 
the benign uterine tumor. Three months after initial diagnosis and surgery the patient is 
asymptomatic and was scheduled for very close follow up.
Conclusion: This case presents an interes with: an early age o f the patient, the rapid evolution 
o f tumor process, difficulties in clinical and histological diagnosis, and in the origin and nature o f 
the tumor (benign or malignant).
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Introduction: As it affects almost every third individual in the population in the Western world, 
non-alcoholic fatty liver disease (NAFLD) represents the most common cause o f chronic liver disease 
and the most common cause o f  liver transplantation. Many metabolic, hemodynamic, hormonal, 
prothrombotic and pro-inflammatory cardiovascular disease (CVD) risk factors exist. Prior research 
suggests that hemorheological determinants, including whole blood viscosity, fibrinogen, and 
hematocrit may be risk factors for ischemic or coronary heart disease. However, the detail relationship 
between serum hemoglobin concentrations and CVD has not been clearly clarified.
Purpose and objectives: We analyzed the potential mechanisms o f the association between 
increased hemoglobin and CVD risk in NAFLD.
Material and methods: The materials are collected by searching keywords (nonalcoholic 
fatty liver disease, cardio vascular diseases risk factors and hemoglobin) from medical database, 
such as: Pubmed, Medline, Embase, Cochrane Register.
Results: The hemoglobin is positively correlated with well-known cardiovascular risk factors 
such as BMf, blood pressure, fasting glucose, total cholesterol, and smoking status after adjusting for 
age. The exact mechanisms whereby increased hemoglobin in NAFLD might lead to a higher risk o f 
CVD are unknown, but the main hypothesis is that increased hemoglobin concentrations lead to 
increased blood viscosity, thereby raising peripheral resistance and reducing blood flow and perfusion to 
the heart. In turn, a reduction o f perfusion has been suggested to accelerate ischemic heart disease. High 
level o f  accumulated iron itself can increase cardiovascular risk by oxidative stress and lipid 
peroxidation. Hemoglobin concentration could affect the cardiovascular system through oxygen supply 
and blood viscosity. In addition, elevated hematocrit level may activate platelets by releasing adenosine 
diphosphate. It is essential to investigate this association in the future.
Conclusions: The emphasis was on the potential role o f increased hemoglobin as a marker o f more- 
severe liver damage and fibrosis in the spectrum o f NAFLD. Abnormal rheological characteristics o f blood 
due to increased hemoglobin might represent an additional mechanism that contributes to the development 
of CVD; these could lead to the development o f novel therapeutic approach in CVD prevention.
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